Journal of Business Ethics 41 (3):287 - 295 (2002)

This paper discusses how adoption of the social dimensions of the marketing concept may unintentionally restrict innovation and corporate entrepreneurship, ultimately reducing social welfare. The impact of social marketing on innovation and entrepreneurship is discussed using the case of multinational pharmaceutical firms that are under pressure when marketing HIV treatments in poor countries.The argument this paper supports is that social welfare may eventually be diminished if forced social responsibility is imposed. The case of providing subsidized AIDS medication to less developed nations is used to illustrate how social blackmail may result in less innovation, entrepreneurship, and product development efforts by the pharmaceutical industry, ultimately reducing social welfare.
Keywords corporate entrepreneurship and social responsibility  innovation and ethics  innovation and public policy
Categories (categorize this paper)
Reprint years 2004
DOI 10.1023/A:1021241129501
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 59,095
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Post-Innovation CSR Performance and Firm Value.Dev Mishra - 2017 - Journal of Business Ethics 140 (2):285-306.

View all 13 citations / Add more citations

Similar books and articles


Added to PP index

Total views
28 ( #378,304 of 2,427,980 )

Recent downloads (6 months)
1 ( #511,645 of 2,427,980 )

How can I increase my downloads?


My notes